High dosage accelerated intermittent theta burst stimulation without precision targeting and dosing in depression: an open-label pilot study

This pilot trial evidenced the antidepressant effect of a high dosage aiTBS protocol comparable with the Stanford Neuromodulation Therapy (SNT) approach but without individualized precision components. Its effectiveness appeared lower than previously reported for SNT. Randomized controlled trials should systematically investigate the contribution of precision components to the overall effectiveness of aiTBS in depression. This trial is a part of a real-world clinical study of non-invasive brain stimulation treatments conducted at our department (preregistered at DRKS-ID: DRKS00024776, drks.de).

Authors

Institutions

Publication Details

Journal
European Archives of Psychiatry and Clinical Neuroscience
Published
2025-07-24
DOI
https://doi.org/10.1007/s00406-025-02067-z
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High dosage accelerated intermittent theta burst stimulation without precision targeting and dosing in depression: an open-label pilot study

Gerrit Burkhardt, Ulrike Vogelmann, Lucia Bulubas, Jonas Björklund et al.
1 links
European Archives of Psychiatry and Clinical Neuroscience
Transcranial Magnetic Stimulation Studies
article

High dosage accelerated intermittent theta burst stimulation without precision targeting and dosing in depression: an open-label pilot study

Gerrit Burkhardt, Ulrike Vogelmann, Lucia Bulubas, Jonas Björklund, Daniel Keeser, André R. Brunoni, Miaoxi Chen, Frank Padberg, Simone Weller, Kai-Yen Chang, Kristin Hagenah
article en

Abstract

This pilot trial evidenced the antidepressant effect of a high dosage aiTBS protocol comparable with the Stanford Neuromodulation Therapy (SNT) approach but without individualized precision components. Its effectiveness appeared lower than previously reported for SNT. Randomized controlled trials should systematically investigate the contribution of precision components to the overall effectiveness of aiTBS in depression. This trial is a part of a real-world clinical study of non-invasive brain stimulation treatments conducted at our department (preregistered at DRKS-ID: DRKS00024776, drks.de).

European Archives of Psychiatry and Clinical NeuroscienceVol. 276(2)
Universidade de São Paulo (BR), German Centre for Cardiovascular Research (DE), Medizinische Zentrum für Gesundheit (DE), Max Planck Institute of Psychiatry (DE), Technical University of Munich (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 77%
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

High dosage accelerated intermittent theta burst stimulation without precision targeting and dosing in depression: an open-label pilot study — Gerrit Burkhardt, Ulrike Vogelmann, et al. · European Archives of Psychiatry and Clinical Neuroscience (2025) | TGRS Research Map | TGRS